Early predictors of 30-day mortality in supratentorial ischemic stroke patients--firstepisode.
A Szczudiik, A Słowik, W Turaj, G Zwolińska, U Wyrwicz-Petkow, K Kasprzyk, M BosakMed Sci Monit 2000; 6(1): CR75-80 :: ID: 432826
Abstract
INTRODUCTION: Prognostic factors following stroke remain to be established.The aim of this study was to determine early prognostic factors related with a 30-day mortality in firstepisode ischemic stroke patients. MATERIALS AND METHODS: The study group comprised 329 consecutive patients,aged between 33 and 99 years (mean age +/- SD 69 +/- 12.6) admitted within 24 hours following their firstsupratentorial ischemic stroke, confirmed either by computer tomography (CT) and/or autopsy. The followingdata were assessed within 24 hours of hospitalization: gender, age, history of diabetes mellitus, historyof ischemic heart disease, obesity, the neurological deficit at entry and after one day, level of consciousnessat entry and after one day, electrocardiographic dysrhythmia at entry, blood pressure at entry and bodytemperature on the first day following stroke. We also assessed particular serum biochemical and hematologicalmarkers including: hematocrit, fibrinogen concentration, platelet count, white blood cell (WBC) count,gamma globulin level, glucose level, cholesterol level, the erythrocyte sedimentation rate (ESR), andcreatinine kinase (CK) level. The end-point for assessment was early death (within 30 days). Statisticalanalysis consisted of univariate analysis and multiple regression. RESULTS: Univariate analysis demonstratedthat an older age, increased neurological deficit at entry and on the next day, decreased consciousnessat entry and on the next day, electrocardiographic dysrhythmia, increased body temperature and glucoselevel, decreased cholesterol level and increased CK level were significantly associated with death after30 days (p < or = 0.05). During multivariate analysis, only a severe neurological deficit (ScandinavianStroke Scale < or = 15 points) both at entry and on the next day (OR = 8.3; 95% CI: 2.83-24.35), decreasedconsciousness within the first 24 hours of hospitalization (OR = 19.2; 95% CI: 2.84-127.77) and electrocardiographicdysrhythmia (OR = 5.2; 95% CI: 2.37-13.77) were associated with death after 30 days. CONCLUSION: A severeneurological deficit lasting 24 hours, decreased consciousness within 24 hours of hospitalization andelectrocardiographic dysrhythmia are the most important indicators of 30-day mortality in patients withfirst-time ischemic stroke.
Keywords: Time Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952